Blueprint Medicines Corporation (LON: 0HOJ)
London
· Delayed Price · Currency is GBP · Price in USD
112.34
+3.04 (2.78%)
Jan 22, 2025, 6:59 PM BST
Blueprint Medicines Employees
Blueprint Medicines had 655 employees as of December 30, 2023. The number of employees increased by 14 or 2.18% compared to the previous year.
Employees
655
Change (1Y)
14
Growth (1Y)
2.18%
Revenue / Employee
508.02K GBP
Profits / Employee
-149.75K GBP
Market Cap
5.73B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Blueprint Medicines News
- 9 days ago - Blueprint Medicines Surges Over 10% as 2025 Growth Strategy Ignites Investor - GuruFocus
- 10 days ago - Blueprint Medicines Corp (BPMC) Unveils 2025 Growth Strategy and Promising Clinical Developments - GuruFocus
- 10 days ago - Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth - PRNewsWire
- 5 weeks ago - Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 6 weeks ago - Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting - PRNewsWire
- 2 months ago - Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs - Seeking Alpha
- 2 months ago - Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst - Benzinga
- 3 months ago - Blueprint Medicines Corporation (BPMC) Q3 2024 Earnings Call Transcript - Seeking Alpha